Sky Investment Group LLC Trims Stock Holdings in GE HealthCare Technologies Inc. $GEHC

Sky Investment Group LLC trimmed its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 1.7% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 50,079 shares of the company’s stock after selling 861 shares during the period. Sky Investment Group LLC’s holdings in GE HealthCare Technologies were worth $3,709,000 at the end of the most recent reporting period.

Several other large investors have also recently bought and sold shares of GEHC. N.E.W. Advisory Services LLC bought a new position in GE HealthCare Technologies in the 1st quarter valued at $25,000. Bogart Wealth LLC boosted its holdings in GE HealthCare Technologies by 260.0% in the 1st quarter. Bogart Wealth LLC now owns 342 shares of the company’s stock valued at $28,000 after purchasing an additional 247 shares during the period. Stonebridge Financial Group LLC boosted its holdings in GE HealthCare Technologies by 165.7% in the 1st quarter. Stonebridge Financial Group LLC now owns 356 shares of the company’s stock valued at $29,000 after purchasing an additional 222 shares during the period. Ameriflex Group Inc. bought a new position in GE HealthCare Technologies in the 4th quarter valued at $31,000. Finally, Olde Wealth Management LLC bought a new position in GE HealthCare Technologies in the 1st quarter valued at $35,000. 82.06% of the stock is owned by institutional investors.

GE HealthCare Technologies Stock Performance

GE HealthCare Technologies stock opened at $74.00 on Friday. The company has a quick ratio of 0.93, a current ratio of 1.16 and a debt-to-equity ratio of 0.85. The company has a market capitalization of $33.79 billion, a PE ratio of 15.16, a P/E/G ratio of 2.93 and a beta of 1.13. The firm has a fifty day simple moving average of $74.54 and a two-hundred day simple moving average of $73.33. GE HealthCare Technologies Inc. has a twelve month low of $57.65 and a twelve month high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings results on Wednesday, July 30th. The company reported $1.06 earnings per share for the quarter, topping the consensus estimate of $0.91 by $0.15. The business had revenue of $5 billion during the quarter, compared to the consensus estimate of $4.96 billion. GE HealthCare Technologies had a net margin of 11.22% and a return on equity of 23.93%. The firm’s revenue for the quarter was up 3.5% on a year-over-year basis. During the same period in the previous year, the firm posted $1.00 earnings per share. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. Research analysts expect that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, August 15th. Shareholders of record on Friday, July 25th were paid a $0.035 dividend. The ex-dividend date of this dividend was Friday, July 25th. This represents a $0.14 annualized dividend and a yield of 0.2%. GE HealthCare Technologies’s payout ratio is currently 2.87%.

Analyst Ratings Changes

Several brokerages have commented on GEHC. Zacks Research raised shares of GE HealthCare Technologies from a “hold” rating to a “strong-buy” rating in a report on Thursday, August 28th. BTIG Research reissued a “buy” rating on shares of GE HealthCare Technologies in a report on Monday, July 14th. Wall Street Zen raised shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating in a report on Saturday, May 31st. Citigroup lifted their price objective on shares of GE HealthCare Technologies from $89.00 to $93.00 and gave the stock a “buy” rating in a report on Thursday, July 31st. Finally, Morgan Stanley dropped their price objective on shares of GE HealthCare Technologies from $78.00 to $74.00 and set an “equal weight” rating for the company in a report on Thursday, July 31st. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat.com, GE HealthCare Technologies currently has an average rating of “Moderate Buy” and an average target price of $88.40.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.